"Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of Covid-19..... Furthermore apabetalone is known to inhibit expression of Angiotensin-converting enzyme 2 (ACE2), the receptor utilized by the novel coronavirus particles to gain entry into human cells."

The above is quoted from Resverlogix's recent news release. Below is an excellent article that just came out in NEJM that is relevant.

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMsr2005760